Generics News

Generics News

Breckenridge Launches Generic Ponstel

Breckenridge announced the launch of Mefenamic Acid 250mg capsules, the generic version of Shionogi's Ponstel.

Mylan Launches Generic Combivir

Mylan announced the launch of Lamivudine and Zidovudine Tablets, the generic version of ViiV's Combivir.

Par Launches Generic Exforge

Par announced the launch of Amlodipine and Valsartan Tablets, the generic version of Novartis' Exforge.

Dr. Reddy's Launches Generic Xopenex

Dr. Reddy's Laboratories announced the launch of Levalbuterol Inhalation Solution, the generic version of Sunovion's Xopenex Inhalation Solution.

Lannett Launches Oxycodone HCl Oral Solution

Lannett announced it has begun shipping Oxycodone HCl Oral Solution, which was approved earlier this month.

Lannett Approved for Oxycodone HCl Oral Solution

Lannett announced it has received approval from the Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone HCl Oral Solution, the equivalent of Lehigh Valley Technologies' listed reference.

Par Resumes Generic Precedex Shipment

Par announced that it has resumed shipping Dexmedetomidine HCl Injection, the generic version of Hospira's Precedex.

Endo Launches Generic Fortesta Gel

Endo announced the introduction of Testosterone Gel 2%, the generic version of its Fortesta Gel.

Mylan Launches Generic Boniva Injection

Mylan announced the launch of Ibandronate Sodium Injection, the generic version of Roche's Boniva Injection.

Teva Launches Generic Baraclude Tablets

Teva announced the launch of Entecavir Tablets, the generic version of Bristol-Myers Squibb's Baraclude.